The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Does faster rituximab infusion for patients with NHL lower cancer care costs?
Carolina Reyes
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Minghan Dai
Employment or Leadership Position - Cedar Associates LLC.
Research Funding - Genentech
Hans-Peter Goertz
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Keith L Dawson
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
John C. Hornberger
Research Funding - Crescendo Bioscience; Genentech; GenomeDx; Genomic Health; Jefferson Medical School; Lilly; Novo Nordisk; Pathwork Diagnostics; Quest; Rockefeller Foundation